SCHEMBL17338596

SCHEMBL17338596

Cc1cc(C)cc(Cc2ccc3[nH]cc(C(=O)NCC(=O)O)c(=O)c3c2)c1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.53
GABRB2 P47870 4/20 0.53
GABRB1 P18505 1/20 0.53
GABRA3 P34903 1/20 0.53
MAPT P10636 3/20 0.50
LMNA P02545 3/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPK1 P28482 1/20 0.48
POLB P06746 3/20 0.48
KDM4E B2RXH2 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 2/20 0.47
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17338611 0.89 GABRA1 (0.52) GABRA1GABRB2GABRB1GABRA3MAPT
SCHEMBL17338622 0.88 GABRA1 (0.65) GABRA1GABRB2GABRB1GABRA3MAPT
SCHEMBL17338604 0.85 GABRA1 (0.62) GABRA1GABRB2GABRB1GABRA3POLB
SCHEMBL17338620 0.85 LMNA (0.61) GABRA1GABRB2GABRB1GABRA3LMNA
SCHEMBL17338615 0.85 GABRA1 (0.61) GABRA1GABRB2GABRB1GABRA3KDM4E
SCHEMBL17338628 0.83 GABRA1 (0.53) GABRA1GABRB2GABRB1GABRA3POLB
SCHEMBL17338623 0.81 GABRA1 (0.52) GABRA1GABRB2GABRB1GABRA3LMNA
SCHEMBL17338638 0.80 POLB (0.50) GABRA1GABRB2GABRB1GABRA3MAPT
SCHEMBL17338542 0.80 GABRA1 (0.64) GABRA1GABRB2GABRB1GABRA3MAPT
SCHEMBL17338645 0.79 GABRA1 (0.79) GABRA1GABRB2GABRB1GABRA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3145914-A1 AGENTS FOR USE IN THE TREATMENT OF CARDIOVASCULAR AND INFLAMMATORY DISEASES STRUCTURALLY BASED ON 4(1 H)-QUINOLONE UCL Business PLC (GB) 2017-03-29 EP disclosed
WO-2015189560-A1 AGENTS FOR USE IN THE TREATMENT OF CARDIOVASCULAR AND INFLAMMATORY DISEASES STRUCTURALLY BASED ON 4(1 H)-QUINOLONE UCL BUSINESS PLC (GB) 2015-12-17 WO disclosed